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Shin'iseihaito (Magnolia Flower Lung-Clearing Decoction; 辛夷清肺湯 xın yí qıng fei tang), a formula of
traditional Japanese kampomedicine (日本漢醫 rì ben hanyı) and traditional Chinesemedicine (TCM;中醫
zhong yı), has been used for the treatment of chronic sinusitis. The objective of this study was to evaluate
the anti-allergic effect of shin'iseihaito on murine allergic reaction induced by nasal sensitization using
ovalbumin (OVA) as an antigen. Extract of shin'iseihaito (SSHT) could reduce the eosinophil, serum IgE and
interleukin (IL)-4 levels, while increased the interferon (IFN)-g levels in allergic mouse. Furthermore,
allergic-murine serum treated with SSHT could not activate passive cutaneous anaphylaxis (PCA) reaction
in murine model. Thus, our study showed that SSHT may possess anti-allergic activity. We suggested that
SSHT may contribute to inhibit the exacerbation of allergic reaction induced by nasal sensitization.
Copyright © 2015, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Many people, approximately 20% of the population, suffer from
allergic rhinitis worldwide.1 From the clinical point of view, allergic
rhinitis causes sneezing, nasal discharge, and nasal obstruction.
From the immunological point of view, allergic rhinitis is a typical
Th2 immune disorder characterized by a high level of antigen
speciﬁc IgE production.2 Because the enhanced IgE production and
inﬂammatory response in rhinitis are due to predominant pro-
duction of Th2 cytokines such as IL-4, the allergic symptoms can be
alleviated by inhibition of Th2 cytokine responses.2 Many re-
searchers have investigated allergic rhinitis using an animal mod-
el.1e3 The model of allergic mice made by OVA sensitization and
challenge had increased serum IgE and eosinophil.3
Shin'iseihaito (SSHT; Magnolia Flower Lung-Clearing Decoction;
辛夷清肺湯 xın yí qıng fei tang), a formula consisting of nine crude
drugs, has been used for the treatment of nasal diseases such as
chronic sinusitis in traditional Japanese kampomedicine (日本漢醫 rì
benhanyı) and traditional Chinesemedicine (TCM;中醫 zhong yı).4,5ogy, Nagoya City University
uho-cho, Mizuho-ku, Nagoya
853 4451.
Minami).
for Food and Biomolecules,
molecules, National Taiwan Unive
ons.org/licenses/by-nc-nd/4.0/).More than 50% of individuals with allergic rhinitis have clinical or
radiographic evidence of chronic sinusitis and 25e58% of individuals
with sinusitis have aeroallergen sensitization.6 Elevated total IgE is a
risk factor for the presence of severe chronic sinusitis.6 Previous
researches suggest that chronic sinusitis could be an atopic disease
driven by IgE sensitization to aeroallergens.6 From these studies,
shin'iseihaitomay be potential useful for allergic disease. However, it
has not been clariﬁed for its role in anti-allergy therapy before.
Thus, in the present study, we investigated whether SSHT is able
to suppress the murine allergic reaction induced by nasal
sensitization.
2. Methods
2.1. Animals
Female Balb/c mice (Japan SLC Ltd, Hamamatsu, Japan) were
used. All animals were 6 week old at the start of the experiments.
2.2. Shin'iseihaito (SSHT; Magnolia Flower Lung-Clearing
Decoction; 辛夷清肺湯 xın yí qıng fei tang)
Shin'iseihaito consists of 3.0 g (daily dose for human) of Gypsum
ﬁbrosum (石膏 shí gao), 3.0 g of tuber of Ophiopogon japonicus (麥門
冬mai men dong), 1.5 g of root of Scutellaria baicalensis (黃芩 huangrsity. Production and hosting by Elsevier Taiwan LLC. This is an open access article
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0.75 g of fruit of Gardenia jasminoides (梔子 zhı zǐ), 1.5 g of bulb of
Lilium lancifolium (百合 bǎi he), 1.5 g of ﬂower ofMagnolia salicifolia
(辛夷 xın yí), 0.5 g of leaf of Eriobotrya japonica (枇杷葉 pí pa ye),
0.75 g of rhizome of Cimicifuga heracleifolia (升麻 sheng ma). These
crude drugs were boiled, ﬁltered, and the decoction was dried to
yield powdered extract (SSHT, 2.5 g for daily human dose). SSHT
(Lot: 14B019) was provided as a generous gift from the Kobayashi
Pharmaceutical Co., LTD (Osaka, Japan). SSHT was suspended in
distilled water to prepare the stock solution at a concentration of
0.1 g/mL and kept in 20 C until use.2.3. Establishment of allergic murine model
Allergic murine models were established based on the previ-
ously described methods with minor modiﬁcations.7,8 The experi-
mental timetable is provided in Fig. 1. Mice were intraperitoneally
administered 0.1 mg/mL OVA (SigmaeAldrich, St. louis, MO, USA)
and 40 mg/ml Al(OH3) in saline at a dosage of 100 mL/mouse.
Sensitization was repeated twice (days 0 and 7), followed by daily
injections of OVA solution (15 mg/mL in saline, 10 mL/each nostril)
into nostrils from day 14e28 (challenge). In the SSHT-treated
group, mice were force-fed SSHT (10 mg/0.1 mL/10 g body weight
(bw)/day, 20-fold of human dosage) from day 13e28. Mice in the
control group were given an equal volume of saline and were
infected using the same method.9 At the end of animal experiment,
the mice were anesthetized and blood samples were collected by
cardiac puncture. All animal procedures were approved by the
Institutional Animal Care and Use Committee at Nagoya City Uni-
versity, Japan.2.4. Leukocyte, eosinophil, IgE, interleukin (IL)-4, and interferon
(IFN)-g in blood sample
Blood samples from the allergic murine model were collected
after 2 h of the last challenge on day 28. The number of leukocyte
and eosinophilia were measured in Tohkai cytopathology institute
(Gifu, Japan).
Concentrations of serum total IgE, IL-4, and IFN-g were evalu-
ated using Mouse IgE ELISA, Mouse IL-4, and Mouse IFN-g ELISA kit
(Biolegend Inc. San Diego, CA, USA) according to themanufacturer's
instructions, respectively. Cytokine levels were calculated using
standard murine recombinant cytokine curves run on the same
immunoplate.Fig. 1. Sensitization and challenge protocols for the experimental allergic murine
model. Mice were sensitized by intraperitoneally (i.p.) injected OVA plus adjuvant
Alum [Al (OH)3] on days 0 and 7, followed by daily intranasal (i.n.) challenge with OVA
solution on days 14e28. Allergic response was monitored on day 28.2.5. Passive cutaneous anaphylaxis reaction (PCA)
Serum IgE antibodies speciﬁc to OVA were also determined
using PCA tests. Anti-OVA serum was collected from previous
allergic rhinitis murine model. The untreated female 6 week-old
Balb/c mice were injected intradermally with 10 mL aliquot of 50
fold diluted anti-OVA of serum in saline into shaved dorsal skin
sites. After two days, OVA (0.1mg) with 0.5% Evans blue (Wako Pure
Chemicals, Osaka, Japan) in saline was injected intravenously into
the tail vein. One hour after antigen challenge, mice were eutha-
nized and the dorsal skin of themousewas removed tomeasure the
pigment area. The area of blue spots on the internal surface of the
skin was measured.10,11
2.6. Statistical analysis
Statistical analysis was performed by repeated one-way analysis
of variance (ANOVA) and the Tukey/Bonferroni/Dunnett's multiple
comparison test. A probability value (P < 0.05) was considered to be
statistically signiﬁcant.
3. Results
3.1. Shin'iseihaito (SSHT; Magnolia Flower Lung-Clearing
Decoction; 辛夷清肺湯 xın yí qıng fei tang) inhibit the eosinophil
level of allergic mice
The leukocyte levels were signiﬁcantly higher in allergic mice
than those in untreatedmice, but those levels were not signiﬁcantly
changed by SSHT-treatment [Fig. 2a]. The eosinophilia levels were
signiﬁcantly higher in allergic mice than those in untreated mice.
Compared to allergic mice, the allergic rhinitis mice treated with
SSHT had signiﬁcantly decreased eosinophil levels (P < 0.01)
[Fig. 2b].
3.2. SSHT inhibit the IgE and IL-4 levels of allergic mice
The IgE levels were higher in allergic mice than those in un-
treated mice. Compared to allergic mice, the allergic mice treated
with SSHT had signiﬁcantly decreased IgE levels [Fig. 3a]. The IL-4
levels were signiﬁcantly higher in allergic mice than those in un-
treated mice. Compared to allergic mice, the allergic mice treated
with SSHT had also signiﬁcantly decreased IL-4 levels (P < 0.01)
[Fig. 3b].
3.3. SSHT activate the IFN-g levels of allergic mice
The IFN-g levels were signiﬁcantly lower in allergic mice than
those in untreated mice. Compared to allergic mice, the allergic
mice treatedwith SSHT had also signiﬁcantly increased IFN-g levels
(P < 0.01) [Fig. 3c].
3.4. SSHT inhibits PCA reaction in allergic mouse
As we found that the eosinophilia and cytokine level of allergic
mouse treated with SSHT were remarkably decreased, we also
conﬁrmed the effect of SSHT on the PCA reaction. The sera con-
taining OVA-speciﬁc anaphylactic antibodies were intradermally
injected and the PCA reaction was measured 1 h after the injection
of the Evans blue solution containing OVA. We observed that PCA
reactions using the sera of allergic mice were exhibited as blue
spots. However, the average sizes of blue spots were signiﬁcantly
decreased in the sera of SSHT-treated allergic mice compared to
those in the sera of allergic mice. No blue spot was observed in the
Fig. 2. Effect of SSHT on (a) leukocyte and (b) eosinophil level in allergic murine model. Data are mean ± S.D. (n ¼ 3). **P < 0.01.
Fig. 3. Effect of SSHT on (a) IgE, (b) IL-4, and (c) IFN-g in allergic murine model. Data are mean ± S.D. (n ¼ 6). **P < 0.01.
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dramatically inhibited the PCA reaction.
4. Discussion
In the present study, we showed that the administration of
Shin'iseihaito (SSHT; Magnolia Flower Lung-Clearing Decoction;辛
夷清肺湯 xın yí qıng fei tang) is capable of suppressing the IgE and
IL-4 levels in murine allergic reaction induced by nasal sensitiza-
tion. SSHT also activated the IFN-g level in same allergic model.
Thus, our result showed that SSHT may return the decreased IFN-g/
IL-4 (Th1/Th2) ratio of the allergic group to the normal range.
This result may also explain the reasons why the administration
of SSHT suppressed the production of anti-OVA IgE antibody
without affecting the development of CD4þ T cells, since IL-4 is the
cytokine known to induce immunoglobulin class switching to IgE.12
IL-4 is known to serve not only as a mast cell growth factor but also
as the major mast cell chemoattachment.13 Therefore, it is possible
that the decrease of Th2 responses in nasal mucosa modulated the
mast cell (IgE)-mediated nasal symptoms, in concert with the
decreased production of anti-OVA IgE antibody.13Our result of PCA reaction also demonstrated that SSHT inhibi-
ted the anaphylaxic factors such as IgE and other antigens. SSHT
may be effective for Type-I allergic reaction. The precise mecha-
nism of the effect of SSHT on PCA reaction is to be determined in a
future study.
Although our results demonstrate that SSHT had anti-
inﬂammatory effect, each individual component of SSHT also
shows anti-inﬂammatory effect. Especially, the ﬂower of M. salici-
folia (辛夷 xın yí) has several anti-inﬂammatory effects including
the inhibitory effects of mast cell-derived histamine release and
PCA reaction.14e17 The fruit of G. jasminoides (梔子 zhı zǐ) inhibits
the histamine release from mast cells and lowered the serum level
of IgE and histamine in allergic murine model.18 The rhizome of A.
asphodeloides (知母 zhı mǔ) inhibits NF-kB transcription activity via
the p38 MAPK and ERK pathway.19 The leaf of E. japonica (枇杷葉 pí
pa ye) had anti-inﬂammatory effect with attenuation of p38MAP
kinase and ERK.20 Some researcher reported that the root of S.
baicalensis (黃芩 huang qín), the bulb of L. lancifolium (百合 bǎi he),
and the tuber of O. japonicus (麥門冬 mai men dong) had anti-
inﬂammatory activity.21e23 Although each component has anti-
inﬂammation effect, this mechanism in detail has been unknown.
Fig. 4. PCA reaction induced by allergic murine serum. The serumwith OVA-speciﬁc IgE from the mice was injected intradermally into the mouse. After two days, OVA was injected
with Evans blue into the tail vein. The positive reactions were shown as blue spots. (a) OVA-induced allergic group, (b) SSHT-treated OVA-induced allergic group, (c) negative
control. (d) The areas of blue spot on the internal surface of the skin were measured. Data are mean ± S.D. (n ¼ 6). **P < 0.01.
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generally composed of several components and the interaction of
themmay enhance the effect of drugs. As further investigation from
this perspective is needed, SSHT may have pronounced anti-
inﬂammatory effects.
5. Conclusion
Administration of Shin'iseihaito (SSHT; Magnolia Flower Lung-
Clearing Decoction; 辛夷清肺湯 xın yí qıng fei tang) is capable of
improving allergic status in OVA-induced allergic murine model.
Further studies are required to conﬁrm the anti-allergy effects and
elucidate the mechanisms of anti-allergy action of SSHT in allergic
murine model.
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